MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Gujarat Inject (Kerala) - BSE: 524238, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Gujarat Inject (Kerala)
Gujarat Inject (Kerala)
BSE: 524238|ISIN: INE659F01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Gujarat Inject (Kerala) is not traded in the last 30 days
Gujarat Inject (Kerala) is not listed on NSE
« Mar 07
Notes to Accounts Year End : Mar '11
1 Consequent to the take over of company''s assets by IFCI Ltd under
 SARFAESI Act, 2002 in November 2008 and final settlement of the loan
 liability thereon, cessation of principal portion of Rs.3,20,79,500/-
 was transferred to Capital Reserve as shown under ''Reserves and
 Surplus''.
 
 2 a) The balances appearing under the head Sundry Creditors, Loans and
 Advances are subject to confirmation.  
 
 b ) All Bank balances amounting to Rs.2,40,025/- are subject to
 confirmation.
 
 3 The accounts pertaining to share allotment and refund accounts
 relating to issue of shares to public have not been reconciled since
 1991 - 92.
 
 4 Contingent Liability
 
 Contingent Liabilities not provided for - Rs.Nil. (previous year - Nil)
 
 5 Entire amount outstanding in Federal Bank Cash Credit Account and
 unsecured loan from
 
 KSIDC Ltd have fallen due for repayment since the financial
 institutions and banks have recalled the loans.
 
 6 Share Application money received in the year 1996 - 97 is still
 pending for allotment.
 
 7 Provisions have not been made in the accounts for interest amounting
 to Rs. 6015842/- and Rs. 2503276/- on Cash Credit Account from the
 Federal Bank Ltd and Unsecured Loan from KSIDC Ltd respectively.
 
 8 The filing fee of Rs. 60,000/- payable to the Registrar of Companies
 consequent to the enhancement of Authorized Share Capital in 1997 - 98
 has not been remitted for which provision has been made in the
 accounts. However, the increase of filing fee vide notification No.
 F1/15/91-CL V w.e.f 01 - 05 - 2000 of Govt. of India, Ministry of
 Finance (Dept. of Company Affairs) amounting to Rs.40,000/- in respect
 of the above enhancement for authorized capital has not been provided
 for.
 
 9 The Company was engaged in manufacturing of Intravenous Fluid on job
 work basis and the activity primarily falls with in a single business.
 Presently, the Company is not running any business operations.  Hence,
 there are no additional disclosures to be provided under Accounting
 Standard (AS) 17 in.  respect of Segment Reporting
 
 Previous years figures have been regrouped, rearranged and reclassified
 
 10 wherever necessary. All the figures have been rounded off to the
 nearest rupee.
Source : Dion Global Solutions Limited
Quick Links for gujaratinjectkerala
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.